How Modern Science Is Changing Advanced Prostate Cancer
Advanced prostate most cancers, additionally referred to as metastatic prostate most cancers, might be obscure. In this episode of Health Matters, a podcast from Mayo Clinic, host Kristen Meinzer speaks with Dr. Elisabeth Heath about what superior prostate most cancers is, how it’s identified, and the way therapy choices have modified in recent times.
Dr. Heath is a genitourinary oncologist and chair of the Department of Oncology at Mayo Clinic in Rochester, Minnesota. She discusses the function of the prostate, when prostate most cancers screening ought to start, and signs that will sign the necessity for additional analysis.
This episode covers:
• Prostate most cancers screening, together with PSA blood assessments and digital rectal exams
• Symptoms of superior and metastatic prostate most cancers
• Diagnostic instruments equivalent to CT scans, bone scans, MRI and PSMA PET scans
• Treatment choices, together with hormone remedy, ARPIs, chemotherapy, radiation and radiopharmaceuticals
• Side results of therapy and the way they’re managed
• Life expectancy and high quality of life with superior prostate most cancers
• Lifestyle modifications that may help total well being throughout therapy
• Ongoing analysis and rising therapies
While superior prostate most cancers typically can’t be cured, new remedies are serving to many sufferers stay longer with a greater high quality of life. Dr. Heath explains how care is tailor-made to every affected person and why shared decision-making is important.
0:00 Introduction to Health Matters
0:45 What Is Advanced (Metastatic) Prostate Cancer?
3:05 How Prostate Cancer Progresses
6:10 Common Symptoms and How the Body Is Affected
9:20 How Advanced Prostate Cancer Is Diagnosed
12:40 Understanding Staging and Spread
16:10 Treatment Options Explained
20:15 Hormone Therapy and Targeted Treatments
24:05 Managing Side Effects and Quality of Life
27:40 Living With Advanced Prostate Cancer
31:10 Ongoing Research and Future Therapies
35:10 Key Takeaways and Patient Guidance
38:20 Final Thoughts and Closing
